The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 06, 2021

Filed:

Nov. 19, 2015
Applicants:

Per Gisle Djupesland, Oslo, NO;

Ramy A. Mahmoud, Yardley, PA (US);

Ole a Andreassen, Oslo, NO;

Lars T. Westlye, Oslo, NO;

Daniel S. Quintana, Oslo, NO;

Knut T. Smerud, Oslo, NO;

Colin David Sheldrake, Wiltshire, GB;

Inventors:

Per Gisle Djupesland, Oslo, NO;

Ramy A. Mahmoud, Yardley, PA (US);

Ole A Andreassen, Oslo, NO;

Lars T. Westlye, Oslo, NO;

Daniel S. Quintana, Oslo, NO;

Knut T. Smerud, Oslo, NO;

Colin David Sheldrake, Wiltshire, GB;

Assignee:

OptiNose AS, Oslo, NO;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 15/08 (2006.01); A61M 15/00 (2006.01); A61K 38/22 (2006.01); A61K 38/28 (2006.01); A61K 38/095 (2019.01); A61K 9/00 (2006.01); A61K 38/08 (2019.01); A61M 29/00 (2006.01); A61M 11/00 (2006.01); A61M 31/00 (2006.01);
U.S. Cl.
CPC ...
A61M 15/08 (2013.01); A61K 9/0043 (2013.01); A61K 38/08 (2013.01); A61K 38/095 (2019.01); A61K 38/22 (2013.01); A61K 38/28 (2013.01); A61M 11/00 (2013.01); A61M 15/009 (2013.01); A61M 15/0013 (2014.02); A61M 15/0021 (2014.02); A61M 15/0098 (2014.02); A61M 29/00 (2013.01); A61M 31/00 (2013.01); A61M 2202/04 (2013.01); A61M 2202/064 (2013.01); A61M 2210/0618 (2013.01);
Abstract

A delivery device for and method of modulating a condition relating to sodal cognition and/or behaviour in a human subject using oxytocin, non-peptide agonists thereof and/or antagonists thereof, comprising: providing a nosepiece to a first nasal cavity of the subject; and providing a supply unit for administering less than 24 IU of oxytocin, non-peptide agonists thereof and/or antagonists thereof through the nosepiece to an upper region posterior of the nasal valve which is innervated by the trigeminal nerve.


Find Patent Forward Citations

Loading…